AGN News and Press, Allergan plc From 07/23/19

As an income and dividend growth investor, I do love dividends, and so do many other investors. Not only do dividends provide a substantial part of overall total return, but they also provide passive income that you can either use to replace existing expenses or, even better, reinvest into you...

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (y...

Read more ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

Well, after a brutal May where the S&P 500 fell 6.58%, the market rebounded sharply in June climbing 6.89%, the largest monthly increase in the index since January earlier this year. At the half-year mark, the S&P 500 is up more than 17%. I entered one new position in June, and there...

DUBLIN , July 19, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the third quarter of 2019. The dividend will be paid on September 13, 2019 to shareholders of record at the clo...

Amgen (NASDAQ: AMGN ) and collaboration partner Allergan (NYSE: AGN ) announce  the commercial availability of MVASI (bevacizumab-awwb), a biosimilar to Roche's ( OTCQX:RHHBY ) Avastin, and KANJINTI (trastuzumab-anns), a biosimilar to Herceptin, in the U.S. More news on: Amgen Inc., ...

Read more ...

THOUSAND OAKS, Calif. , July 18, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin ® (bevacizumab), and KANJINTI TM (trastuzumab-anns), a biosimilar to Herceptin ® (trastuzu...